Predictive factors of acoustic neuroma growth


  • Dimitrios Kikidis Department of Otorhinolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital, Greece
  • Ioannis Xenellis Department of Otorhinolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital, Greece
  • Efthymios Kyrodimos Department of Otorhinolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital, Greece
  • Aristeidis Sismanis Department of Otorhinolaryngology, Head and Neck Surgery, National and Kapodistrian University of Athens, Hippocrateion General Hospital, Greece



Acoustic neuroma, Growth, Prognostic factors


Background:Since the use of magnetic resonance imaging (MRI) as the gold standard for acoustic neuroma diagnosis, the size of the majority of newly diagnosed acoustic neuromas has decreased. Management strategy is challenging, especially in young patients with small tumors. Therefore, prognostic factors for tumor growth may facilitate physicians to optimize treatment choice.

Methods:Patients diagnosed with acoustic neuromas were recruited in this study. Gender, age, side, presence of hearing loss, tinnitus, vertigo, unsteadiness, other symptoms, hearing level in the affected ear and tumor growth at the first follow up MRI were recorded. Two primary endpoints were set: overall acoustic neuroma (AN) growth and growth correlated to treatment plan change (clinically significant growth). Multivariate and survival analysis were conducted to this end.  

Results:85 patients were finally included in the study. The most prevalent presenting symptoms were hearing loss (76%), tinnitus (56%) and unsteadiness (46%). The tumour grew in size in less than 50% of the cases during the observation period. Clinically significant growth was observed in 27% of the cases. Mean initial diameter was 10.41mm and mean final follow-up diameter (diameter at the end of the observation period) 12.73 mm. Following binary logistic regression analysis, tumour growth during the initial follow up visit was found to be correlated in a statistically significant level to overall tumour growth (p-value 0.023). Regarding clinically significant growth, three factors were found to be statistically significant: growth at the initial visit (p-value 0.02), initial diameter (p-value 0.045) and existence of unsteadiness at diagnosis (p-value 0.02).

Conclusions:Acoustic neuroma overall growth is not identical to clinically significant growth. Growth at first visit is a significant prognostic factor and intervention potential should be considered under this perspective.


Cabral R, King TT, Scott DF. Incidence of postoperative epilepsy after a transtentorial approach to acoustic nerve tumours. J Neurol Neurosurg Psychiatry. 1976;39(7):663-5.

Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005;26(1):93-7.

Miller T, Lau T, Vasan R, Danner C, Youssef AS, van Loveren H, Agazzi S. Reporting success rates in the treatment of vestibular schwannomas: are we accounting for the natural history? J Clin Neuro Sci. 2014;21(6):914-8.

Baschnagel AM, Chen PY, Bojrab D, Pieper D, Kartush J, Didyuk O, Naumann IC, Maitz A, Grills IS. Hearing preservation in patients with vestibular schwannomatreated with gamma knife surgery. J Neurosurg. 2013;118(3):571-8.

Han JH, Kim DG, Chung HT, Paek SH, Park CK, Kim CY, et al. Hearing preservation in patients with unilateral vestibular schwannoma who undergo stereotactic radiosurgery: reinterpretation of the auditory brainstem response. Cancer. 2012;118(21):5441-7.

Patel TR, Chiang VL. Secondary neoplasms after stereotactic radiosurgery. World Neurosurg. 2014;81(3-4):594-9.

Bennett M, Haynes DS. Surgical approaches and complications in the removal of vestibular schwannomas .Neurosurg Clin N Am. 2008;19(2):331-43.

Stangerup SE, Caye TP. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am. 2012;45(2):257-68.

Martin TP, Senthil L, Chavda SV, Walsh R, Irving RM. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol. 2009;30(3):381-5.

Solares CA, Panizza B. Vestibular schwannoma: an understanding of growth should influence management decisions. Otol Neurotol. 2008;29(6):829-34.

BozorgGrayeli A, Kalamarides M, Ferrary E, Bouccara D, Gharem H, Rey A. Conservative management versus surgery for small vestibular schwannomas. Acta Otolaryngol. 2005;125(10):1063-8.

Tomita Y, Tosaka M, Aihara M, Horiguchi K, Yoshimoto Y. Growth of primary and remnant vestibular schwannomas: a three-year follow-up study. World Neurosurg. 2015;83(6):937-44.

Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;1146:1-35.

Committee on Hearing and Equilibrium Guidelines for the Evaluation of Hearing Preservation in Acoustic NeuromaOtolaryngol Head Neck Surg. 1995;113(3):179-80.

Kondziolka SH, Mousavi H, Kano JC, Flickinger LD. Lunsford the newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus. 2012;33:8.

Whitehouse K, Foroughi M, Shone G, Hatfield R. Vestibular schwannomas when should conservative management be reconsidered? Br J Neurosurg. 2010;24:185-90.

Nikolopoulos TP, Fortnum H, Donoghue G, Baguley D. Acoustic neuroma growth: a systematic review of the evidence. Otol Neurotol. 2010;31(3):478-85.

Silverstein H, McDaniel A, Norrell H, Wazen J. Conservative management of acoustic neuroma in the elderly patient. Laryngoscope. 1985;95(7):766-70.

Charabi S, Tos M, Thomsen J, Charabi B, Mantoni M. Vestibular schwannoma growth: the continuing controversy. Laryngoscope. 2000;110(10):1720-5.

Stangerup SE, Caye TP, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27(4):547-52.

Smouha EE, Yoo M, Mohr K, Davis RP. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm. rosenberg si natural history of acoustic neuromas. Laryngoscope. 2000;110(4):497-508.

Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope. 2000;110(4):497-508.

Battaglia A, Mastrodimos B, CuevaR. Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol. 2006;27(5):705-11.

Strasnick B, Glasscock ME, Haynes D, Menomey SO, Minor LB. The natural history of untreated acoustic neuromas. Laryngoscope. 1994;104(9):1115-9.

Jethanamest D, Rivera AM, Ji H, Chokkalingam V, Telischi FF, Angeli SI. Conservative management of vestibular schwannoma: predictors of growth and hearing. Laryngoscope. 2015;125(9):2163-8.

Moffat DA, Kasbekar A, Axon PR, Lloyd SK. Growth characteristics of vestibular schwannomas. Otol Neurotol. 2012;33(6):1053-8.

Langenberg R, Bondt BJ, Nelemans PJ, Dohmen AJ, Baumert BG, Stokroos RJ. Predictors of volumetric growth and auditory deterioration in vestibular schwannomas followed in a wait and scan policy. Otol Neurotol. 2011;32(2):338-44.

Mulder JJ, Kaanders JH, Overbeeke JJ, Cremers CW7. Radiation therapy for vestibular schwannomas. Curr Opin Otolaryngol Head Neck Surg. 2012;20(5):367-71.

Kondziolka D. Hearing after gamma knife surgery. J Neurosurg. 2012;117(5):874-5.

Husseini ST, Piccirillo E, Sanna M. On malignant transformation of acoustic neuroma/vestibular schwannoma 10 years after gamma knife stereotactic radiosurgery. Skull Base. 2011;21(2):135-8.

Nonaka Y, Fukushima T, Watanabe K, Friedman AH, Cunningham CD, Zomorodi AR. Surgical management of vestibular schwannomas after failed radiation treatment. Neurosurg Rev. 2016;39(2):303-12.

Shuto T, Inomori S, Matsunaga S, Fujino H. Microsurgery for vestibular schwannoma after gamma knife radiosurgery. Acta Neurochir (Wien). 2008;150(3):229-34.

Elliott A, Hebb AL, Walling S, Morris DP, Bance M. Hearing preservation in vestibular schwannoma management. Am J Otolaryngol. 2015;36(4):526-34.

Carlson ML, Tveiten OV, Driscoll CL, Goplen FK, Neff BA,et al. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg. 2015;122(4):833-42.

Bloch O, Sughrue ME, Kaur R, Kane AJ, Rutkowski MJ, Kaur G, Yang I, Pitts LH, Parsa AT. Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol. 2011;102(2):281-6.

Li D, Tsimpas A, Germanwala AV. Analysis of vestibular schwannoma size: a literature review on consistency with measurement techniques. Clin Neurol Neurosurg. 2015;138:72-7.

Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reportingresults in vestibular schwannoma. Otol Neurotol. 2003;24(4):642-8.

Niemczyk K, Vaneecloo FM, Lemaitre L, Lejeune JP, Skarzynski H, Dubrulle F, Vincent C. The growth of acoustic neuromas in volumetric radiologic assessment. Am J Otol. 1999;20(2):244-8.






Original Research Articles